Search research articles
Contact Us
Filters
Showing results (241-250 of 388) with videos related to
Page
of 39
Sort By:
Kidney International
|
October 31, 2020
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer
Camillo Porta, Aristotelis Bamias, Farhad R Danesh, et al.
Journal of Bone Oncology
|
February 12, 2026
Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational study
Paolo Taurisano, Ester Cornacchia, Maria Fara De Caro, et al.
Cancer Medicine
|
July 22, 2014
Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries
Camillo Porta, Antonin Levy, Robert Hawkins, et al.
Kidney International
|
December 5, 2020
KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation
Jolanta Małyszko, Aristotelis Bamias, Farhad R Danesh, et al.
Journal of Translational Medicine
|
August 16, 2022
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs
Marzia Del Re, Stefania Crucitta, Federico Paolieri, et al.
Hepatic Oncology
|
September 8, 2018
Tivantinib in MET-high hepatocellular carcinoma patients and the ongoing Phase III clinical trial
Lorenza Rimassa, Camillo Porta, Ivan Borbath, et al.
Cancer Immunology, Immunotherapy : CII
|
December 14, 2020
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC
Marzia Del Re, Federico Cucchiara, Eleonora Rofi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 3, 2022
Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma
Matteo Santoni, Francesco Massari, Marc R Matrana, et al.
Cancer Treatment Reviews
|
June 22, 2011
Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapies
Bernard Escudier, Susanne Osanto, Börje Ljungberg, et al.
Clinical Genitourinary Cancer
|
March 20, 2022
Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison
Matteo Santoni, Gaetano Aurilio, Francesco Massari, et al.
Page
of 39
Search research articles
Search
Showing results (241-250 of 388) with videos related to
Sort By:
Page
of 39
Kidney International
|
October 31, 2020
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer
Camillo Porta, Aristotelis Bamias, Farhad R Danesh, et al.
Journal of Bone Oncology
|
February 12, 2026
Psychosocial impact of COVID-19 pandemic on patients with solid malignancies and bone metastases (PsyCO-B): a multicentre prospective observational study
Paolo Taurisano, Ester Cornacchia, Maria Fara De Caro, et al.
Cancer Medicine
|
July 22, 2014
Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries
Camillo Porta, Antonin Levy, Robert Hawkins, et al.
Kidney International
|
December 5, 2020
KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation
Jolanta Małyszko, Aristotelis Bamias, Farhad R Danesh, et al.
Journal of Translational Medicine
|
August 16, 2022
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs
Marzia Del Re, Stefania Crucitta, Federico Paolieri, et al.
Hepatic Oncology
|
September 8, 2018
Tivantinib in MET-high hepatocellular carcinoma patients and the ongoing Phase III clinical trial
Lorenza Rimassa, Camillo Porta, Ivan Borbath, et al.
Cancer Immunology, Immunotherapy : CII
|
December 14, 2020
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC
Marzia Del Re, Federico Cucchiara, Eleonora Rofi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 3, 2022
Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma
Matteo Santoni, Francesco Massari, Marc R Matrana, et al.
Cancer Treatment Reviews
|
June 22, 2011
Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapies
Bernard Escudier, Susanne Osanto, Börje Ljungberg, et al.
Clinical Genitourinary Cancer
|
March 20, 2022
Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison
Matteo Santoni, Gaetano Aurilio, Francesco Massari, et al.
Page
of 39